AQR Capital Management’s Pacific Biosciences PACB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$21.1K Buy
16,989
+6,067
+56% +$7.52K ﹤0.01% 3278
2025
Q1
$12.9K Buy
+10,922
New +$12.9K ﹤0.01% 3140
2024
Q2
Sell
-108,364
Closed -$406K 2657
2024
Q1
$406K Buy
108,364
+36,274
+50% +$136K ﹤0.01% 2033
2023
Q4
$707K Buy
72,090
+33,837
+88% +$332K ﹤0.01% 1736
2023
Q3
$319K Buy
38,253
+4,510
+13% +$37.7K ﹤0.01% 1993
2023
Q2
$449K Buy
33,743
+17,519
+108% +$233K ﹤0.01% 1823
2023
Q1
$188K Buy
+16,224
New +$188K ﹤0.01% 2060
2022
Q1
Sell
-62,416
Closed -$1.28M 2270
2021
Q4
$1.28M Sell
62,416
-75,003
-55% -$1.53M ﹤0.01% 1427
2021
Q3
$3.51M Buy
137,419
+13,061
+11% +$334K 0.01% 909
2021
Q2
$4.35M Sell
124,358
-35,423
-22% -$1.24M 0.01% 870
2021
Q1
$5.32M Sell
159,781
-26,258
-14% -$875K 0.01% 813
2020
Q4
$4.83M Buy
186,039
+63,370
+52% +$1.64M 0.01% 795
2020
Q3
$1.21M Sell
122,669
-31,445
-20% -$310K ﹤0.01% 1321
2020
Q2
$532K Buy
+154,114
New +$532K ﹤0.01% 1715
2017
Q1
Sell
-50,029
Closed -$190K 2233
2016
Q4
$190K Sell
50,029
-73,760
-60% -$280K ﹤0.01% 2158
2016
Q3
$1.11M Sell
123,789
-72,391
-37% -$649K ﹤0.01% 1688
2016
Q2
$1.38M Buy
196,180
+45,444
+30% +$320K ﹤0.01% 1484
2016
Q1
$1.28M Buy
+150,736
New +$1.28M ﹤0.01% 1475
2015
Q4
Sell
-51,323
Closed -$188K 2287
2015
Q3
$188K Sell
51,323
-20,949
-29% -$76.7K ﹤0.01% 2072
2015
Q2
$416K Sell
72,272
-37,382
-34% -$215K ﹤0.01% 1855
2015
Q1
$641K Sell
109,654
-36,500
-25% -$213K ﹤0.01% 1604
2014
Q4
$1.15M Sell
146,154
-5,840
-4% -$45.8K ﹤0.01% 1581
2014
Q3
$746K Buy
151,994
+59,200
+64% +$291K ﹤0.01% 1761
2014
Q2
$573K Hold
92,794
﹤0.01% 1923
2014
Q1
$496K Buy
92,794
+1,300
+1% +$6.95K ﹤0.01% 2048
2013
Q4
$479K Buy
91,494
+78,594
+609% +$411K ﹤0.01% 2088
2013
Q3
$71K Buy
+12,900
New +$71K ﹤0.01% 2449